Our Story
Our Story
Great innovations often begin with a simple question: Can science solve problems that existing technologies cannot? Our startup was founded on that belief. As we explored the growing challenges in therapeutic delivery and biomaterial performance, we recognized a critical opportunity—hydrogel technologies had enormous potential, but their clinical and commercial translation remained limited.
Driven by this challenge, we began developing advanced hydrogel platforms designed to deliver precision, safety, and consistent therapeutic performance. Our work combines biomaterial engineering, rigorous scientific validation, and data-driven development to transform laboratory discoveries into scalable healthcare solutions.
From the earliest research stages, our goal has been clear: build technologies that can move beyond the lab and make a real impact in global healthcare. By integrating preclinical validation, regulatory awareness, and scalable manufacturing strategies, we are creating hydrogel platforms that are not only scientifically robust but also commercially viable.
Today, our startup is focused on advancing innovative hydrogel technologies that can enable new therapeutic possibilities. Through continuous research, strategic intellectual property protection, and global collaboration, we aim to translate scientific innovation into reliable healthcare solutions that benefit patients worldwide.
We want to turn cutting-edge biomaterial science into practical, scalable technologies that shape the future of therapeutic delivery.
Our Mission
Our mission is to develop patient-friendly drug delivery platforms and advance healthcare through innovative, scientifically validated hydrogel technology. We are committed to developing safe, scalable, and regulatory-compliant solutions to accelerate translation from research to real-world clinical and commercial success.
Our Vision
Our vision is to become a pioneering PharmTech innovation Centre developing next-generation drug delivery solutions and be known as a trusted patient-care partner. We aspire to set new benchmarks in precision therapeutics, and patient comfort, ensuring accessible, efficient, and transformative healthcare solutions across diverse medical and cosmetic applications worldwide.
Our Strengths
At AlcoMatrix Pharma Private Limited, our greatest strength lies in the integration of scientific innovation with practical healthcare solutions. Our proprietary hydrogel patch technology is developed through advanced biomaterial research, enabling targeted drug delivery that enhances therapeutic performance, patient comfort, and treatment accessibility.
Our multidisciplinary team brings strong expertise in formulation development, material characterization, and preclinical evaluation. By combining research excellence with data-driven validation, we ensure that every solution meets high standards of safety, efficacy, and reproducibility across diverse therapeutic and cosmetic applications.
Another key strength is our deep understanding of regulatory pathways and commercialization readiness. With knowledge aligned to global compliance frameworks, we support smoother approvals, scalable manufacturing, and efficient market translation, helping transform innovative concepts into reliable and impactful healthcare products.
About Team
Management of AlcoMatrix Pharma
Our strong team has expertise in biomaterial synthesis, characterization, and regulatory compliance, with special focus on development on niche pharmatech, healthtech, and medtech solutions.
Dr. Ruchi Chawla
Shweta Singh
Pandey Ajay Sanjay
Team Capabilities:
Strength in Knowledge and Execution
Development & Optimization of Material
- Delivery materials
- Delivery systems
- Sensing materials
- Replication of existing materials
Characterization of Materials
- Physical characterization
- Chemical characterization
- Microbiological characterization
Knowledge of Regulatory Guidelines
- Patent landscaping
- ICH (International Council for Harmonisation)
- CDSCO (Central Drugs Standard Control Organization)
- FDA (Food and Drug Administration)
Pre-clinical Evaluation
- Pharmacokinetic studies
- Bio-distribution analysis
- Pharmacological assessment
- Immunological evaluation